News
1 October 2026
Fonko Strengthens Indonesia’s Oncology Industry Capacity
JAKARTA — PT Fonko International Pharmaceuticals has recorded several key milestones in the development of oncology drug manufacturing in Indonesia. These achievements include securing European Union Good Manufacturing Practice (EU GMP) certification in 2025, developing a range of "first copy" products for cancer therapy, and obtaining halal certification for its…
25 September 2026
Consistently Maintaining Halal Standards, Dexa Group Wins IHYA 2026
TANGERANG — PT Ferron Par Pharmaceuticals, a member of Dexa Group, has won the 2026 Indonesia Halal Industry Award (IHYA) from the Ministry of Industry of the Republic of Indonesia in the Large Industrial Enterprise Category, Subcategory of Best Pharmaceuticals and Traditional Medicines. This award recognizes Dexa Group’s consistency in…
24 September 2026
From Medications to Facilities, Ferron Strengthens Support for Cancer Patients
JAKARTA — Indonesia recorded 474,083 new cases and 283,299 deaths due to cancer, according to 2024 Global Cancer Observatory (GLOBOCAN) data. This situation underscores the critical role of Ferron Par Pharmaceuticals in expanding its support for cancer patients—from delivering access to medications to strengthening chemotherapy support facilities through the provision…
6 June 2024
Implementation of “Deal with Care”: Dexa Group Donates Ambulance to Puskesad Health Education Center
Dexa Group has enhanced its corporate value of "Deal with Care" by donating an ambulance to the Army Health Education Center (Pusdikkes Puskesad) to improve healthcare services for the community around the Pusdikkes Puskesad Hospital. Mr. V Hery Sutanto, the leader of Dexa Medica, handed over the ambulance to Colonel…
30 May 2024
Dexa Group advocates for the development of traditional herbal medicine through Indonesia Indigenous Modern Medicine in the webinar titled “Jamu: Dulu, Kini, dan Nanti.”
Indonesia's potential wealth in natural resources, as the second-largest country in terms of biodiversity, boasting over 28 thousand species of plants and 2,848 medicinal plants, presents significant opportunities for the development of natural medicine and Indonesia Indigenous Modern Medicine (OMAI) phytopharmaceuticals. Dra. Reri Indriani, Senior Expert Pharmacist and Food Supervisor…
28 May 2024
Encouraging the Development of Phytopharmaca, Dexa Group Participates in the National Jamu Week Event by BPOM.
Dexa Group is a research-based pharmaceutical company committed to actively participating in developing phytopharmaca. This commitment aligns with the government's efforts to address the dependency on imported raw materials for medicines by utilizing the country's natural resources to produce phytopharmaca. "The government provides full support for developing medicines, including natural…
17 May 2024
Stimuno Wins 14th Top Brand For Kids Award
Stimuno has once again secured the Top Brand For Kids Award, marking its 14th accolade in recognition of its unwavering commitment to quality and adherence to halal production standards from beginning to end, ensuring its consumers' comfort and safety. Marketing Magazine and Frontier Group have bestowed the Top Brand For…
23 April 2024
Prof. Raymond Tjandrawinata, The Pioneer of Indonesia’s Indigenous Modern Medicine, Ranks Among The Top Three Pharmaceutical Scientists
Clinical and Molecular Pharmacologist Prof. Raymond Tjandrawinata of Dexa Group and Unika Atma Jaya, who also pioneers the development of Indonesia Indigenous Modern Medicine (OMAI), has achieved third place among the top pharmaceutical scientists in Indonesia. The AD Scientific Index provided this ranking based on a system that analyzes scientific…
8 April 2024
Implementation of ESG, Dexa Group Supports Research Facility at Rumah Perubahan
To encourage sustainable environment and implement Environmental, Social, and Governance (ESG) principles, Dexa Group supports research facilities at Rumah Perubahan by providing microscopes. The microscopes were presented by Dexa Group's Business Development and Scientific Affairs Director, Prof. Raymond Tjandrawinata, to the Founder of Rumah Perubahan, Prof. Rhenald Kasali on Friday,…
13 March 2024
Dexa Group Receives 3 Prestigious Awards from PRIA 2024
Successfully implementing public relations programs that create positive impact to society and company, Corporate Communications Dexa Group has won three awards at the Public Relations Indonesia Awards (PRIA) which took place on Thursday, March 7 2024 in Denpasar, Bali. Dexa Group's Corporate Communications won awards in the PR Program category…